Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

SPONSORED

Early Recognition of axSpA

04/26/2022

 

Learn more about axSpA, course of the disease, symptomology, and patient evaluation to make informed decisions on appropriate referrals, in this video presentation by Julio Gonzalez Paoli, MD, FACR.

Advertisement

Stay in the Know

Rheumatology & Arthritis Newsletter

Advertisement

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

Advertisement

Popular Articles

Poll: Immunoautonomics for Predicting Treatment Outcomes
Poll
Poll: Immunoautonomics for Predicting Treatment Outcomes
04/16/2020
In your opinion, do you feel that immunoautonomics can accurately predict tumor necrosis factor inhibitor treatment outcomes in patients with rheumatoid arthritis?YesNoUnsure
In your opinion, do you feel that immunoautonomics can accurately predict tumor necrosis factor inhibitor treatment outcomes in patients with rheumatoid arthritis?YesNoUnsure
In...
04/16/2020
Rheumatology & Arthritis
5 Questions About the G-CAN Consensus Statement on New Gout Terminology
Q&As
5 Questions About the G-CAN Consensus Statement on New Gout Terminology
02/20/2020
The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) has developed a consensus statement regarding the labels and definitions used for disease states of gout. G-CAN sought to overcome...
The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) has developed a consensus statement regarding the labels and definitions used for disease states of gout. G-CAN sought to overcome...
...
02/20/2020
Rheumatology & Arthritis
Which Influenza Vaccine Is More Immunogenic in Rheumatoid Arthritis?
Which Influenza Vaccine Is More Immunogenic in Rheumatoid Arthritis?
01/16/2020
A high-dose trivalent inactivated influenza vaccine (HD-TIV) is not only safe for patients with seropositive rheumatoid arthritis (RA), but also more immunogenic than a standard-dose quadrivalent influenza vaccine...
A high-dose trivalent inactivated influenza vaccine (HD-TIV) is not only safe for patients with seropositive rheumatoid arthritis (RA), but also more immunogenic than a standard-dose quadrivalent influenza vaccine...
A...
01/16/2020
Rheumatology & Arthritis
Leading Organizations Develop Classification Criteria for IgG4‐Related Disease
12/03/2019
A multispecialty group assembled by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) has developed and validated the first international set of classification criteria for...
A multispecialty group assembled by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) has developed and validated the first international set of classification criteria for...
A...
12/03/2019
Rheumatology & Arthritis
Entheseal Lesions at the Hip and Pelvis Are Prevalent in Ankylosing Spondylitis
11/08/2019
Radiographic entheseal lesions at the hip and pelvic region are more prevalent in patients with ankylosing spondylitis (AS) compared with controls, according to findings of a new study presented at the 2019 American...
Radiographic entheseal lesions at the hip and pelvic region are more prevalent in patients with ankylosing spondylitis (AS) compared with controls, according to findings of a new study presented at the 2019 American...
...
11/08/2019
Rheumatology & Arthritis

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement